Skip to main content

Neuroscience meeting: Emory University starts center to research autism and other disorders

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American


SAN DIEGO—"Trust in a Bottle." That's the marketing slogan for a product called Liquid Trust, a spray that purportedly increases trust.

Don't buy it. The oxytocin craze has now outpointed the pheromone frenzy for attracting a public enthralled by the easy fix.

The fascination is fueled by 25 to 30 studies in humans that show how the hormone's properties affect social relationships.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Don't buy it. No one knows whether, over time, your oxytocin recepters will desensitize and leave you a socially inept wreck.

That doesn't mean that oxytocin therapy will remain off limits forever. Emory University just announced at this week's Society for Neuroscience meeting that it is establishing a Center for Translational Social Neuroscience. (Translation of "Translational": take basic research and bring it into clinical practice.)

The objective will be to bring in bigwig scientists like Frans B.M. de Waal from the school's Yerkes National Primate Research Center to marshal a body of basic research on social bonding and translate it into drugs or behavioral interventions that can help autistic children and those suffering from the kinds of social deficits that can occur with schizophrenia. These studies will also shed light on how the normal social brain works

"The overall goal is to foster collaboration between people trying figure to out how to treat autism patients and people who are working with animals who can come up with clever ways of stimulating the social brain and bring these people together to make translation happen," says Larry Young, the center's director,  who uses prairie voles (unusual because they are monogamous mammals—see photo) to study social relationships. Young has begun to do research on developing Melanotan, an off-patent drug (originally a tanning agent) that stimulates oxytocin production.

An autistic kid would not be spritzed constantly with Melanotan or some other substance, but would instead use it in a therapy session. The chemical might help in reading emotion in a therapist's face or performing other excercises to foster an empathetic perspective. Even then, shopping on the Internet for this stuff is a bad idea.

Image Credit: Emory University

 

Gary Stix, the neuroscience and psychology editor for Scientific American, edits and reports on emerging advances that have propelled brain science to the forefront of the biological sciences. Stix has edited or written cover stories, feature articles and news on diverse topics, ranging from what happens in the brain when a person is immersed in thought to the impact of brain implant technology that alleviates mood disorders like depression. Before taking over the neuroscience beat, Stix, as Scientific American's special projects editor, oversaw the magazine's annual single-topic special issues, conceiving of and producing issues on Einstein, Darwin, climate change and nanotechnology. One special issue he edited on the topic of time in all of its manifestations won a National Magazine Award. Stix is the author with his wife Miriam Lacob of a technology primer called Who Gives a Gigabyte: A Survival Guide to the Technologically Perplexed.

More by Gary Stix